Cytokinetics, Incorporated (CYTK) Q1 2025 Earnings Call Transcript

  • Cytokinetics, Incorporated (NASDAQ:CYTK ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Diane Weiser - Senior Vice President, Corporate Affairs Robert Blum - President & Chief Executive Officer Andrew Callos - Executive Vice President & Chief Commercial Officer Fady Malik - Executive Vice President, R&D Isaac Ciechanover - EVP Corporate Development and Chief Business Officer Stuart Kupfer - Senior Vice President & Chief Medical Officer Sung Lee - Executive Vice President & Chief Financial Officer Conference Call Participants Sean McCutcheon - Raymond James Salim Syed - Mizuho Gena Wang - Barclays Paul Choi - Goldman Sachs Cory Kasimov - Evercore ISI Roanna Ruiz - Leerink Partners Akash Tewari - Jefferies Charles Duncan - Cantor Fitzgerald Tessa Romero - JPMorgan Maxwell Skor - Morgan Stanley David Lebowitz - Citigroup Inc. Mayank Mamtani - B. Riley Securities Srikripa Devarakonda - Truist Securities James Condulis - Stifel Jason Zemansky - Bank of America Leland Gershell - Oppenheimer Jason Butler - Citizens JMP John Gionco - Needham & Company Yasmeen Rahimi - Piper Sandler Operator Good afternoon, and welcome to Cytokinetics' First Quarter 2025 Conference Call.